SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
Rhea-AI Summary
SOPHiA GENETICS (Nasdaq: SOPH) will release its third quarter 2025 financial results before U.S. markets open on Tuesday, November 4, 2025.
The company will host a conference call and webcast to discuss the results and business outlook on Nov 4, 2025 at 8:00 a.m. EDT / 2:00 p.m. CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations website and a replay will be available on the site after the call.
Positive
- None.
Negative
- None.
News Market Reaction – SOPH
In the Oct 21 session, SOPH gained 0.24%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform that analyzes complex multimodal data – including genomics, radiomics, clinical, biological, and digital pathology data – to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-third-quarter-2025-on-november-4-2025-302589274.html
SOURCE SOPHiA GENETICS